췌장 선방세포암 1예

A Case of Pancreatic Acinar Cell Carcinoma

  • Lee, Hwa-Jung (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Ji, Jun-Ho (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Park, Seung-Chan (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Park, Jung-Chul (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Choi, Eun-Jung (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Seo, Hye-Jin (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Lee, Won-Sik (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Lee, Jung-Lim (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Bae, Byung-Jo (Department of Surgery, Daegu Fatima Hospital) ;
  • Shon, Kyung-Rak (Department of Pathology, Daegu Fatima Hospital) ;
  • Lee, Kyung-Hee (Department of Internal Medicine, College of Medicine, Yeungnam University)
  • 발행 : 2008.12.30

초록

Acinar cell carcinoma is a rare tumor that represents 1~2% of all pancreatic cancers. Clinical and radiologic findings are inconclusive in this disease. Acinar cell carcinoma is characterized by rapid progression and early metastasis, which lead to its poor prognosis. A 41-year-old man was admitted to our hospital for abdominal pain. Abdominal computed tomography (CT) and positron emission tomography-computed tomography (PET-CT) showed a splenic mass, which was being invaded by a pancreatic tail mass and which had increased $^{18}F$-fluorodeoxyglucose (FDG) uptake. Primary radical distal pancreatectomy and splenectomy were performed. Pathologic findings revealed an acinar cell carcinoma of the pancreas. The patient underwent a total gastrectomy three months later because of gastric recurrence. Four months later, multiple hepatic metastases were discovered, and the patient underwent a left hepatectomy. During treatment with capecitabine, there was no evidence of tumor progression for 14 months. We report a case of metastatic pancreatic acinar cell carcinoma, which did not progress for an extended period while the patient was being treated with capecitabine.

키워드